The embargo on all abstracts part of the 2019 Supportive Care in Oncology Symposium lifted at 5:00 p.m. ET on October 21, 2019.
Meeting Information and Publications
Meet the News Planning Team (to be announced)
2018 Press Releases
- Side Effects From Certain Immunotherapies May Be Higher Than Initially Reported
An analysis of nearly 2,800 people with non-small cell lung cancer (NSCLC) who received the immune checkpoint inhibitors nivolumab (Opdivo), pembrolizumab (Keytruda), or atezolizumab (Tecentriq) found that unexpected medical problems, known as adverse events, may be more common than reported in the initial trials that led to the approval of these therapies. These findings will be presented at the upcoming 2018 Palliative and Supportive Care in Oncology Symposium in San Diego, California. Read more.
- Artificial-Intelligence Smartphone App Significantly Reduced Severity of Cancer Patients’ Pain and Hospital Admissions
A study of 112 people with metastatic solid tumors found that the use of artificial intelligence (AI)-based smartphone app reduced both the severity of patients’ reported pain and hospital admissions. After an eight-week period, patients who used the AI-powered app to monitor and address pain experienced a 20% reduction in the severity of pain and had nearly 70% lower risk of pain-related hospital admissions than patients not using the app. These findings will be presented at the upcoming 2018 Palliative and Supportive Care in Oncology Symposium in San Diego, California. Read more.
- 2018 Symposium Highlights Notable Oncology Research in Palliative Care
Five noteworthy studies exploring key research regarding the biologic mechanisms of symptoms and caring for patients’ psychosocial and spiritual needs during cancer treatment and at end of life will be presented at the 2018 Palliative and Supportive Care in Oncology Symposium. Taking place from November 16–17, at the Hilton San Diego Bayfront in San Diego, abstracts presented at the symposium will provide information that is vital to the entire cancer care continuum. Read more.